1422500-60-4

1422500-60-4 structure

Name: Ziresovir
Chemical Name: N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine
CAS Number: 1422500-60-4
Molecular Formula: C₂₂H₂₅N₅O₃S
Molecular Weight: 439.531
Catalog: Signaling Pathways Anti-infection RSV
Create Date: 2018-07-01 20:35:57
Modify Date: 2025-08-25 14:25:42
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species[1].

Name	N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine
Synonyms	4-Quinazolinamine, N-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5H)-yl)-6-methyl- N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine

Description	Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> RSV
Target	EC50: 3 nM (RSV F)[1]
References	[1]. Scott SA, et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5(2):108-17.